Ashvattha Therapeutics
Redwood City, CA
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
avttx.comCompany Details
Founded
- 2015
Employees
- Between 10 - 50 employees
Raised
- $148,000,000
Headquarters Location
- Redwood City, CA
Public
- No
Acquired
- No
CEO
Jeffrey Cleland
Founders
- Justin HanesSujatha KannanKannan RangaramanujamJeffrey Cleland
Company Collections
These are collections Ashvattha Therapeutics is a part of. Click on the collection name to view similar companies.